The Hindu-VIT Biotech Conclave in Chennai discusses new frontiers in science
The Biotech Conclave 2026 in Chennai brought together industry leaders and academics to discuss advancements in biotechnology and life sciences. Key themes included precision medicine, drug discovery, and India's growing role in global vaccine manufacturing.
Why it matters
This event highlights India's strategic shift toward self-reliance in pharmaceutical research and its growing influence in global healthcare innovation.
The Biotech Conclave 2026, organised by VIT Chennai in association with The Hindu , was inaugurated at Taj Connemara, Chennai, on Friday (September 11, 2026), bringing together academics, researchers, and industry leaders to discuss developments in biotechnology and life sciences.
Themed ‘Exploring New Frontiers in Science’, the conclave focuses on biomedical research, drug discovery, healthcare technologies, biotechnology innovation, and translating scientific research into applications.
The inaugural session was attended by N. Ram, director, The Hindu Group, and L.V. Navaneeth, CEO, The Hindu . It was presided over by G. Viswanathan, founder and chancellor, Vellore Institute of Technology (VIT), with Suchitra Ella, co-founder and managing director, Bharat Biotech and CII President-Designate, as chief guest.
Welcoming the gathering, Suresh Nambath, editor, The Hindu , said the sessions were structured to focus on scientific theory and its practical applications, including the fundamentals of precision medicine, and urged participants to engage with the speakers.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in